Provided by Tiger Trade Technology Pte. Ltd.

Disc Medicine

78.67
+0.02000.03%
Pre-market: 78.760.0900+0.11%08:39 EDT
Volume:549.44K
Turnover:43.16M
Market Cap:3.02B
PE:-11.99
High:79.95
Open:78.56
Low:75.88
Close:78.65
52wk High:99.50
52wk Low:40.00
Shares:38.39M
Float Shares:32.95M
Volume Ratio:0.99
T/O Rate:1.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.5619
EPS(LYR):-6.0116
ROE:-39.08%
ROA:-23.96%
PB:4.69
PE(LYR):-13.09

Loading ...

Disc Medicine Presents Updated Positive Data From Rally-Mf Phase 2 Trial in Patients With Myelofibrosis (Mf) and Anemia at the 2026 American Society of Clinical Oncology (Asco) Annual Meeting

THOMSON REUTERS
·
Jun 02

Disc Medicine Presents Updated Positive Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire
·
Jun 02

Press Release: LABRADOR IRON ORE ROYALTY CORPORATION - CHANGES TO THE BOARD OF DIRECTORS AND COMMITTEE LEADERSHIP

Dow Jones
·
Jun 02

Disc Medicine - Bitopertin Phase 3 Apollo Trial Topline Data Expected in Q4 2026

THOMSON REUTERS
·
Jun 01

Disc Medicine - Launches Expanded Access Program for Bitopertin for Epp and Xlp Patients in U.S.

THOMSON REUTERS
·
Jun 01

Disc Medicine Launches Expanded Access Program for Bitopertin for EPP Patients

GlobeNewswire
·
Jun 01

Press Release: CHAMPION IRON REPORTS ITS FY2026 FOURTH QUARTER RESULTS

Dow Jones
·
May 28

H.C. Wainwright Keeps Their Buy Rating on Disc Medicine (IRON)

TIPRANKS
·
May 27

Should Disc Medicine’s RALLY-MF Data and Wider Pipeline Reveal a Pivotal Inflection for IRON’s Narrative?

Simply Wall St.
·
May 17

Disc Medicine Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
May 15

Morgan Stanley Raises Price Target on Disc Medicine to $80 From $75, Keeps Overweight Rating

MT Newswires Live
·
May 14

Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2026 Congress

GlobeNewswire
·
May 12

Disc Medicine joins H.C. Wainwright BioConnect investor conference fireside chat

Reuters
·
May 11

Disc Medicine to Participate in Upcoming Investor Conferences

GlobeNewswire
·
May 11

Disc Medicine (IRON) Gets a Buy from LifeSci Capital

TIPRANKS
·
May 10

Disc Medicine (IRON) Receives a Buy from H.C. Wainwright

TIPRANKS
·
May 07

Disc Medicine Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 05

Disc Medicine reports Q1 EPS ($1.65), consensus ($1.73)

TIPRANKS
·
May 05

Disc Medicine posts smaller-than-expected Q1 net loss

Reuters
·
May 05

Disc Medicine Q1 EPS $(1.65) Beats $(1.73) Estimate

Benzinga Earnings
·
May 05